A Rising Tide: Pharma Takes to the Seas

The Demand for Sustainability and Resiliency Are Continuing to Drive More Pharma Shipments to the Seas

24

January

  • 3PM London / 10AM New York
  • Free

Why attend?

Key Learning Objective:

  • ​​Understand typical pharma supply chains​ 
  • ​​​Learn about the main benefits of ocean freight over air freight and vice versa​​ 
  • ​​Understand the main obstacles from a quality assurance perspective of moving freight by sea and how can these be overcome​ 
  • ​​A look forward – the pharma cold chain five years from today​  

 

When shipping pharmaceuticals internationally, the decision of ocean shipping versus air shipping might seem obvious if speed is the only factor at play when sending sensitive medical supplies and drugs. For the last several years, however, more companies have decided to embrace ocean shipping for the delivery of their medicines. Industry experts Alan Kennedy and Allan Klinge discuss how—with more cold chain control, a lower carbon footprint, and lower costs — ocean-going vessels often have clear advantages over air freight.

Our experts have extensive experience in the ocean freight and pharmaceutical industries. Throughout the discussion, attendees will have the opportunity to learn from these speakers about a variety of topics, including an overview of pharma cold chain, the impact which COVID-19 had in changing that cold chain, and where the industry is headed over the next five years. Discussions will also include an overview of current ocean freight trends and innovations for reducing carbon emissions, options for real-time visibility, and regulatory obstacles.

We encourage all interested individuals to register for this insightful educational event and panel discussion. The event will provide invaluable information and perspectives on crucial topics like sustainability, cost reduction, and critical temperature maintenance, and how innovative refrigerated container designs can enhance reliability of the pharmaceutical cold chain. This is a unique opportunity to gain expert insights, learn about industry trends, and join a community of forward-thinking professionals. Don’t miss out! Register now and secure your spot!

Speakers

Select a speaker to learn more

Back
Allan Klinge
CEO, Klinge

Mr. Klinge plans, develops, implements, and evaluates the organization’s administration function and performance. He participates in the development of the corporation’s plans and programs. Mr. Klinge is also responsible for directing, managing and coordinating all sales and marketing activities for Klinge Corporation. He coordinates efforts between the sales and engineering departments; leads the development and implementation of marketing initiatives; and, helps to identify, design and implement new market opportunities, products and plans. Mr. Klinge joined Klinge Corporation in 2007. He previously worked at a research firm in Washington, DC. Mr. Klinge has a Master’s Degree from Harvard University and a Bachelors Degree from Dartmouth College.

Next speaker
Back
Alan Kennedy
Executive Director, GDP Universal Compliance Initiative

With a specialized focus on optimizing pharmaceutical supply chains, Alan has cultivated a track record of implementing transformative reforms and industry best practices. His cross-industry experience has shaped him into a forward-thinking strategist, and his collaborations with leading global companies have enriched his understanding of complex logistics challenges. A founder of the independent GDP Universal Compliance Initiative, he is spearheading a collaborative industry program designed to reform, harmonize and elevate the global distribution standards for life-saving medicines and vaccines.

Next speaker

Enquiry